The stock of Clearmind Medicine Inc (NASDAQ: CMND) has increased by 10.14 when compared to last closing price of 1.38. Despite this, the company has experienced a -11.63% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-01-02 that Vancouver, Canada, Jan. 02, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval from the Macau International Intellectual Property Office.
Is It Worth Investing in Clearmind Medicine Inc (NASDAQ: CMND) Right Now?
The 36-month beta value for CMND is at -1.50.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CMND is 2.96M, and currently, shorts hold a 3.79% of that float. The average trading volume for CMND on January 02, 2025 was 1.12M shares.
CMND’s Market Performance
CMND’s stock has seen a -11.63% decrease for the week, with a 21.59% rise in the past month and a 26.67% gain in the past quarter. The volatility ratio for the week is 15.97%, and the volatility levels for the past 30 days are at 10.38% for Clearmind Medicine Inc The simple moving average for the last 20 days is 10.57% for CMND stock, with a simple moving average of 13.90% for the last 200 days.
CMND Trading at 9.39% from the 50-Day Moving Average
After a stumble in the market that brought CMND to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.54% of loss for the given period.
Volatility was left at 10.38%, however, over the last 30 days, the volatility rate increased by 15.97%, as shares surge +12.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.90% lower at present.
During the last 5 trading sessions, CMND fell by -13.95%, which changed the moving average for the period of 200-days by +13.85% in comparison to the 20-day moving average, which settled at $1.3727. In addition, Clearmind Medicine Inc saw 10.14% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CMND
The total capital return value is set at -1.21. Equity return is now at value -267.90, with -133.31 for asset returns.
Currently, EBITDA for the company is -8.71 million with net debt to EBITDA at 1.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.71.
Conclusion
In conclusion, Clearmind Medicine Inc (CMND) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
